Editas Medicine (EDIT) Cash & Equivalents (QoQ) (2015 - 2025)
Editas Medicine (EDIT) Cash & Equivalents (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Editas Medicine | 243.69 Mn | 97.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.47% |
| Sep 30, 2025 | 19.57% |
| Jun 30, 2025 | -0.11% |
| Mar 31, 2025 | 5.44% |
| Dec 31, 2024 | 37.26% |
| Sep 30, 2024 | 48.71% |
| Jun 30, 2024 | -6.91% |
| Mar 31, 2024 | -44.01% |
| Dec 31, 2023 | 49.81% |
| Sep 30, 2023 | -62.62% |
| Jun 30, 2023 | 71.15% |
| Mar 31, 2023 | -8.83% |
| Dec 31, 2022 | -32.83% |
| Sep 30, 2022 | 24.38% |
| Jun 30, 2022 | -19.67% |
| Mar 31, 2022 | 3.62% |
| Dec 31, 2021 | -21.69% |
| Sep 30, 2021 | -23.07% |
| Jun 30, 2021 | -4.81% |
| Mar 31, 2021 | 154.09% |